Shares of Johnson & Johnson JNJ inched 0.10% higher to $170.39 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.25% to 4,163.29 and Dow Jones Industrial Average DJIA falling 0.16% to 34,327.79. This was the stock's third consecutive day of gains. Johnson & Johnson closed $3.26 below its 52-week high ($173.65), which the company reached on January 26th.
The stock underperformed when compared to some of its competitors Monday, as Roche Holding AG Part. Cert. RHHVF rose 1.00% to $340.00, Merck & Co. Inc. MRK rose 2.02% to $79.87, and Pfizer Inc. PFE rose 0.22% to $40.11. Trading volume (5.1 M) remained 2.2 million below its 50-day average volume of 7.3 M.